|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-2-26
|
|
pubmed:abstractText |
Survival benefit of non-small-cell lung cancer (NSCLC) patients treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors is predicted by high EGFR gene copy number and by strong EGFR protein expression. Clinical relevance of these features in patients treated with chemotherapy has not been reported.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
447-52
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17082511-Adult,
pubmed-meshheading:17082511-Aged,
pubmed-meshheading:17082511-Antineoplastic Agents,
pubmed-meshheading:17082511-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17082511-Disease-Free Survival,
pubmed-meshheading:17082511-Female,
pubmed-meshheading:17082511-Follow-Up Studies,
pubmed-meshheading:17082511-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17082511-Humans,
pubmed-meshheading:17082511-Immunohistochemistry,
pubmed-meshheading:17082511-In Situ Hybridization, Fluorescence,
pubmed-meshheading:17082511-Kaplan-Meier Estimate,
pubmed-meshheading:17082511-Lung Neoplasms,
pubmed-meshheading:17082511-Male,
pubmed-meshheading:17082511-Middle Aged,
pubmed-meshheading:17082511-Patient Selection,
pubmed-meshheading:17082511-Proportional Hazards Models,
pubmed-meshheading:17082511-Protein Kinase Inhibitors,
pubmed-meshheading:17082511-Receptor, Epidermal Growth Factor,
pubmed-meshheading:17082511-Time Factors,
pubmed-meshheading:17082511-Treatment Outcome,
pubmed-meshheading:17082511-Tumor Markers, Biological
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy.
|
|
pubmed:affiliation |
University of Colorado Health Sciences Center, Aurora, CO, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
